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 Letter to the Editor 
come). This local understanding of causal effects prevents an a 
priori clustering of factors that could modify the effect of the 
inter vention, as well as a drawing of global conclusions without 
examining the most striking potential effect modifiers. The anal-
yses of Pigott et al.  [1] represent an extraordinary strength by 
combining a meta-analytic strategy with an analysis of a large 
original study that takes different stages of depression treatment 
into account. Nevertheless, the authors continue to aggregate 
across all other factors.
 Conversely, clinical wisdom and more sophisticated treatment 
models [e.g.  6 ] follow the logic of ‘adaptive indication’ implicitly 
taking effect modifiers into account. This does not apply to anti-
depressants alone. Suppose a patient who contacts a general prac-
titioner: regardless of the question the patient may pose (e.g. ‘Do 
marathons hurt my knees?’ or ‘Should I take antidepressants?’), 
the practitioner would wisely consider the potential effect modi-
fiers (e.g. the patient’s condition, including treatment history or 
preference). Rather than responding with a dichotomous ‘yes’ or 
‘no’, the practitioner would provide the best empirically informed 
answer by stating: ‘It depends!’ Future research should tell us 
more precisely on what. 
 The answer to whether treatments like pharmacotherapy and 
psychotherapy ameliorate a given disorder (e.g. depression) may 
strongly impact patients, treatment decisions and health care ex-
penditures. After their reanalysis of previous meta-analyses and 
the large STAR * D study, Pigott et al.  [1] concluded that antide-
pressants were ‘only marginally efficacious’ (p. 267) compared to 
placebo. Given that ‘it is unlikely that a syndrome as polymorphic 
and widely diagnosed as major depressive disorder (MDD) will 
reflect a single process’ [2, p.131], the present statement will in-
quire about the conclusions to be drawn from the data of Pigott et 
al., while neglecting the typical methodological critique of spe-
cific meta-analyses (e.g. study selection, data analysis, etc.) and 
assuming accuracy in their main finding. 
 Results from meta-analyses essentially present weighted aver-
ages of average effect sizes per study  [3] . Conclusions based on 
meta-analyses tend to be generalized across depressive patients 
varying in sex, age, family status, illness characteristics, comor-
bidity and (duration of) prior treatment, as well as across studies 
differing both in methodology and analysis of influential factors 
(e.g. agents affecting different biochemical pathways). However, 
there is compelling evidence indicating that these and other fac-
tors can modify causal treatment effects [e.g.  4 ]. A marginal over-
all effect in combination with considerable effect modification 
would still suggest that some patients experience strong positive 
effects after being administered an antidepressant. 
 Recent conceptual work  [5] has shown how a better grounding 
of scientific analyses on the definition of ‘causal effects’ can coun-
teract potential overgeneralization, which is known as one of the 
main pitfalls of meta-analyses. In the proposed counterfactual 
model, a causal effect of a particular treatment (e.g. antidepres-
sant intervention) is defined to be present if a particular person 
shows a different outcome after treatment than if the same person 
had been assigned to another condition (e.g. wait list) at the time 
of the treatment decision. Hence, antidepressant effects are con-
sidered to vary across individuals and time (in addition to out-
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